David B. Damon

The Evolution of High-Throughput Experimentation in Pharmaceutical Development and Perspectives on the Future

Steven M. Mennen, Carolina Alhambra, C. Liana Allen et al. · Organic Process Research & Development · 2019 · 535 citations

Pharmaceutical Research, Pharmaceutical Innovation, Hit Identification +25

Biarylcarboxylic Acids and -amides:  Inhibition of Phosphodiesterase Type IV versus [³H]Rolipram Binding Activity and Their Relationship to Emetic Behavior in the Ferret

Allen J. Duplantier, Michael S. Biggers, Robert Chambers et al. · Journal of Medicinal Chemistry · 1996 · 143 citations · Full text

Direct observation by X‐ray analysis of the tetrahedral “intermediate” of aspartic proteinases

B. Veerapandian, Jon Cooper, Andrej Săli et al. · Protein Science · 1992 · 121 citations · Full text

Protein Assembly, Molecular Biology, Chemical Biology +16

Asymmetric Synthesis of the Cholesteryl Ester Transfer Protein Inhibitor Torcetrapib

David B. Damon, Robert W. Dugger, Stephen E. Hubbs et al. · Organic Process Research & Development · 2006 · 62 citations

Combinatorial Chemistry, Medicinal Chemistry, Biosynthesis +15

Synthesis of the ketodifluoromethylene dipeptide isostere

David B. Damon, Dennis J. Hoover · Journal of the American Chemical Society · 1990 · 62 citations

Altmetrics, Molecular Sciences, Information +11